Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Gross Profit: 2012-2020

Historic Gross Profit for Ironwood Pharmaceuticals (IRWD) over the last 9 years, with Dec 2020 value amounting to $386.4 million.

  • Ironwood Pharmaceuticals' Gross Profit rose 0.43% to $115.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $340.7 million, marking a year-over-year increase of 11.41%. This contributed to the annual value of $386.4 million for FY2020, which is 4.49% down from last year.
  • Ironwood Pharmaceuticals' Gross Profit amounted to $386.4 million in FY2020, which was down 4.49% from $404.5 million recorded in FY2019.
  • In the past 5 years, Ironwood Pharmaceuticals' Gross Profit ranged from a high of $404.5 million in FY2019 and a low of $272.1 million during FY2016.
  • Its 3-year average for Gross Profit is $368.3 million, with a median of $386.4 million in 2020.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Gross Profit skyrocketed by 81.95% in 2016 and then dropped by 4.49% in 2020.
  • Ironwood Pharmaceuticals' Gross Profit (Yearly) stood at $272.1 million in 2016, then climbed by 2.61% to $279.2 million in 2017, then climbed by 12.43% to $313.9 million in 2018, then rose by 28.88% to $404.5 million in 2019, then declined by 4.49% to $386.4 million in 2020.